Compare

Bain Capital GSS Investment Corp. vs EQV Ventures Acquisition Corp. II vs Cantor Equity Partners IV, Inc. vs Drugs Made In America Acquisition II Corp.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Bain Capital GSS Investment Corp. BCSS	EQV Ventures Acquisition Corp. II EVAC	Cantor Equity Partners IV, Inc. CEPF	Drugs Made In America Acquisition II Corp. DMII
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	n/a	$8.92M	$6.13M	$4.19M
EPS (Diluted)	n/a	n/a	n/a	n/a
Operating cash flow	n/a	-$627.9K	-$62.9K	-$1.02M
Free cash flow	n/a	n/a	n/a	n/a
Cash & equivalents	$0	$1.09M	$25.0K	$223
Total assets	$465.84M	$470.27M	$456.95M	$504.96M
Total liabilities	$16.39M	$18.13M	$95.4K	$17.80M
Shareholders' equity	-$15.20M	-$16.38M	$142.4K	-$17.77M
Return on year-end equity	n/a	n/a	n/m	n/a
Shares outstanding	n/a	n/a	n/a	13.70M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Bain Capital GSS Investment Corp.	EQV Ventures Acquisition Corp. II	Cantor Equity Partners IV, Inc.	Drugs Made In America Acquisition II Corp.
Latest	n/a	n/a	n/a	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a